Ian T. Bothwell - 13 May 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (ZEOX)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian Bothwell
Issuer symbol
ZEOX
Transactions as of
13 May 2021
Net transactions value
-$40,800
Form type
4
Filing time
17 May 2021, 21:45:30 UTC
Previous filing
12 May 2021
Next filing
25 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale $13,500 -50,000 -0.03% $0.2700 149,695,000 13 May 2021 Direct
transaction OCEL Common Stock Sale $12,000 -50,000 -0.03% $0.2400 149,645,000 14 May 2021 Direct
transaction OCEL Common Stock Sale $10,300 -50,000 -0.03% $0.2060 149,595,000 17 May 2021 Direct
transaction OCEL Common Stock Sale $5,000 -25,000 -0.02% $0.2000 149,570,000 17 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.